With increasing numbers of children and adults undergoing allogeneic haematopoietic stem cell transplantation , neurotoxicity is emerging as an important cause of transplant-related morbidity. 3 The calcineurin inhibitor cyclosporine A is the most frequently used agent for prevention of GvHD in both adult and paediatric patients.
Aurinia Pharmaceuticals Inc. today announced it will host a Lupus Nephritis expert breakfast on Thursday, August 4th from 8:00am to 9:30am EDT in New York. The topics of the presentations will include current treatments for Lupus Nephritis, its disease burden, as well as pharmacoeconomic and pricing dynamics for new products for less common diseases in the US market place.
In a small clinical study, the combination of voclosporin with standard of care resulted in a 57% complete remission rate, which is much higher than current standard of care. We consider this company undervalued at its current stock price and initiate coverage with a Buy rating and long-term price target = $8.73 to $14.38.